Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

InVivo Therapeutics (NVIV)

InVivo Therapeutics Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVIV
DateTimeSourceHeadlineSymbolCompany
21/03/202418:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202419:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202401:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202419:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202418:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/02/202417:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202313:35Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202313:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/12/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
30/11/202315:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/11/202321:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/09/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/08/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/202321:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
25/04/202322:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202313:55Business WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/03/202321:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202318:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202211:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202222:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
18/11/202221:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202211:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:NVIV